tiprankstipranks
Trending News
More News >
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market

Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?

Compare
601 Followers

Galectin Therapeutics (GALT) Ownership Overview

19.88%4.79%5.49%4.49%65.36%
19.88% Insiders
5.49% Other Institutional Investors
4.49% ETFs
65.36% Public Companies and Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 14.76% of the company’s stock is owned by Institutional Investors, 19.88% is owned by Insiders, and 65.36% is owned by Public Companies and Individual Investors.
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 10.27% of the company’s stock is owned by Institutional Investors, 19.88% is owned by Insiders, and 4.49% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$7540
Dec 26, 2024
xxxxxxxxxxxxx
$8100
Dec 26, 2024
xxxxxxxxxxxxx
$8100
Dec 26, 2024
xxxxxxxxxxxxx
$11045

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,328,981Insider16.32%14,150,704
2,156,086Institution3.41%2,953,838
2,055,791Institution3.25%2,816,434
1,045,541Insider1.65%1,432,391
834,592Insider1.32%1,143,391
549,723Institution0.87%753,121
487,597Institution0.77%668,008
197,530Institution0.31%270,616
142,832Insider0.23%195,680
110,273Institution0.17%151,074

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,055,791Institution3.25%2,816,434
487,597Institution0.77%668,008
197,530Institution0.31%270,616
110,273Institution0.17%151,074
65,073Institution0.10%89,150
37,318Institution0.06%51,126
27,623Institution0.04%37,844
26,902Institution0.04%36,856
7,500Institution0.01%10,275
5,351Institution<0.01%7,331

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,385,631Institution2.19%1,898,314
716,632Institution1.13%981,786
360,941Institution0.57%494,489
102,018Institution0.16%139,765
79,308Institution0.13%108,652
68,382Institution0.11%93,683
51,484Institution0.08%68,989
45,525Institution0.07%62,369
18,382Institution0.03%25,183
4,665Institution<0.01%6,391

FAQ

Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 5.49% of the company's stock is held by institutional investors, 19.88% is held by insiders, and 65.36% is held by retail investors.
    What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 5.49% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
      What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.36% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
        Who owns the most shares of Galectin Therapeutics Inc (GALT)?
        Richard E Uihlein owns the most shares of Galectin Therapeutics Inc (GALT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis